Publication | Closed Access
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
35
Citations
30
References
2018
Year
Smoking intensity was significantly associated with the number of relapses during natalizumab treatment.
| Year | Citations | |
|---|---|---|
2001 | 6.9K | |
2006 | 3.3K | |
2011 | 2.7K | |
2007 | 1.7K | |
2013 | 1.4K | |
1973 | 472 | |
2015 | 387 | |
2009 | 318 | |
2001 | 318 | |
2001 | 295 |
Page 1
Page 1